Stay updated with breaking news from Mary Rollman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supply-chain issues have plagued many executives of Connecticut small, midsize and global manufacturers in recent years. New Britain-based Stanley Black & Decker announced in July it would initiate a supply chain overhaul that would help generate $1.5 billion to $2 billion in savings over three years.
3 Strategies To Address The Biggest Concerns Facing Generic Drug Makers By Roger van den Heuvel, Mary Rollman, and Jeff Stoll, KPMG Generic drugs, which account for 90% of the prescriptions filled in the U.S., have been a constraint on pharmaceutical inflation for decades, with many payers touting their “drug trend” — a measure of spending growth of pharmaceutical drugs. Generic drug sales have grown 5.7% annually, from 2014 to 2019, and additional patent expirations could sustain 5.4% generic drug growth to $497 billion by 2025. Amid this opportunity for generic drug makers to capitali...